Archive for November 2019

Trump Nominates New FDA Commissioner

Senate Hearing Set for Nov. 20 By Pete Evich, AAHP Govt. Relations   On Nov. 1, President Trump nominated Stephen Hahn, chief medical executive of the MD Anderson Cancer Center in Houston, to be the next U.S. Food and Drug Administration (FDA) commissioner. If confirmed by the Senate, a process readm more…

Read More

4 Types of FDA Inspections & How to Prepare

Risk. It’s a hot word in the homeopathic industry right now. Even before the FDA issued its draft guidance, the agency used a risk-based approach to site inspections. With the 2012 Safety and Innovation Act, the agency nixed a set inspection calendar and began visiting manufacturers “in accordance with a readm more…

Read More

Little-Known Facts About 3 Unique Starting Materials

By Mary Beth Watkins and Eric Foxman   The array of substances used for homeopathic drug products is wide and varied. Many homeopathic starting materials also have uses outside of our industry and might be familiar by their common English names. We’ve reformatted “Drug Facts” panels to give you several readm more…

Read More

State of Homeopathic Medicines at Retail

By Mark Land, AAHP President   Every year or so I survey my local CVS store for the number and type of homeopathic drug products on their shelves. This year I decided to add a few Internet retailers as well for a broader look at the market. In general, homeopathic readm more…

Read More